Precision Imaging to Evaluate Kaposi Sarcoma

Precision Imaging to Evaluation Kaposi Sarcoma (PRIME-KS)

AIMS 2 & 3:

In this study the investigators seek to formally compare reproducibility and accuracy of KS lesion size measurements between SkinScan3D and the current standard of care manual measurement method. The investigators will then test the SS3D device on 100 patients in a variety of real-world practice locations to determine whether the device will be usable, acceptable, appropriate, and feasible in routine care settings.

Inclusion Criteria - Aim 2 (Patients):

• Adults age ≥18 years old
• Histopathology-confirmed Kaposi Sarcoma
• At least 3 skin lesions
• Capable of informed consent
• On treatment for Kaposi Sarcoma

Exclusion Criteria - Aim 2 (Patients):

• Patients not initiating Kaposi Sarcoma treatment
• Very ill patients requiring hospitalization

Inclusion Criteria - Aim 3 (Patients):

• Adults age ≥18 years old
• Histopathology-confirmed Kaposi Sarcoma
• Capable of informed consent
• Initiating treatment for Kaposi Sarcoma

Exclusion Criteria - Aim 3 (Patients):

• Patients with Kaposi Sarcoma that participated in Aim 1 or Aim 2
• Prior or ongoing Kaposi Sarcoma treatment